[The mechanism and pulmonary-protective effects of endothelin-1 receptor antagonist in chronic obstructive pulmonary diseases rat model].

Zhonghua nei ke za zhi [Chinese journal of internal medicine]

Volumn 49, Issue 5, 2010, Pages 380-384

  Chen, Yan ^a   Chen, Ping ^b   Masayuki, Hanaoka ^b   Peng, Hong ^b   Yunden, Droma ^b   Keishi, Kubo ^b  

^a CENTRAL SOUTH UNIVERSITY   (China)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT; BOSENTAN; CASP3 PROTEIN, RAT; CASPASE 3; CYCLO(TRP ASP PRO VAL LEU); CYCLO(TRP-ASP-PRO-VAL-LEU); CYCLOPEPTIDE; ENDOTHELIN A RECEPTOR; GELATINASE A; GELATINASE B; INTERLEUKIN 1BETA; MMP2 PROTEIN, RAT; SULFONAMIDE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL; APOPTOSIS; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; DRUG ANTAGONISM; DRUG EFFECT; LUNG; LUNG EMPHYSEMA; MALE; METABOLISM; PATHOLOGY; RAT; SPRAGUE DAWLEY RAT;

ANIMALS; ANTIHYPERTENSIVE AGENTS; APOPTOSIS; CASPASE 3; INTERLEUKIN-1BETA; LUNG; MALE; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; PEPTIDES, CYCLIC; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; PULMONARY EMPHYSEMA; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, ENDOTHELIN A; SULFONAMIDES; TUMOR NECROSIS FACTOR-ALPHA;

EID: 79952199057     PISSN: 05781426     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (0)